- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03929562
Alcohol Screening and Pre-Operative Intervention Research Study (ASPIRE)
October 24, 2022 updated by: Anne Fernandez, University of Michigan
This study aims to learn more about how to improve patients' health before and after a scheduled surgery by examining acceptability and initial efficacy of pre-operative alcohol use reduction interventions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study is a randomized clinical pilot trial that assesses preliminary intervention efficacy of a two-session health coaching intervention relative to brief advice among pre-operative elective surgical patients and evaluates intervention acceptability.
Study subjects will be outpatients at a large health system in the midwestern United States and fulfill the study's inclusion criteria.
Subjects will be randomized to one of two intervention conditions: Health Coaching or Brief Advice.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- The University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Referred for elective or semi-elective surgery or pre-operative assessment in the next 120 days
- Meet criteria for "risky drinking" as defined by study staff
Exclusion Criteria:
- Displays or shows evidence of psychotic symptoms
- Undergoing surgeries that commonly require local anesthesia only
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Brief advice
One brief advice session, resource brochure, standard of care, and an infographic about alcohol and surgical health at patient's pre-existing pre-operative clinical visit.
|
One 10-minute brief advice session
|
|
Experimental: Health coaching
Two health coaching sessions, resource brochure, standard of care
|
Two 45-minute health coaching sessions will use a non-confrontation motivational interviewing (MI) style.
Intervention delivery will include expressing concern about unhealthy drinking, providing feedback linking alcohol use and health (related to surgery and general health), advising the patient regarding abstinence or alcohol use reduction, and working with the patient to set a drinking goal if he/she is ready to change.
We will also include a personalized feedback component to address the links between pre-operative alcohol use and postoperative morbidity/mortality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Alcohol Weekly Use
Time Frame: Baseline through 4 months
|
Average (i.e.
mean) weekly alcohol use was assessed using the timeline followback measure.
The timeline followback assesses alcohol use using a calendar format on which participants report the number of standard drinks they consumed each day during the assessment period.
In the United States, one standard drink (or one alcoholic drink equivalent), is defined as any beverage containing 0.6 oz or 14 grams of pure alcohol.
|
Baseline through 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of Intervention as Measured by the Post-intervention Evaluation.
Time Frame: Weeks 1-6, Immediately following intervention
|
Interventions will be considered 'acceptable' if the average acceptability rating reaches a threshold of 3 or more on a 4-point Likert scale where a score of 4 is most acceptable. Satisfaction
|
Weeks 1-6, Immediately following intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne Fernandez, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 20, 2019
Primary Completion (Actual)
July 19, 2021
Study Completion (Actual)
August 17, 2021
Study Registration Dates
First Submitted
April 24, 2019
First Submitted That Met QC Criteria
April 24, 2019
First Posted (Actual)
April 29, 2019
Study Record Updates
Last Update Posted (Actual)
November 15, 2022
Last Update Submitted That Met QC Criteria
October 24, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00156743
- 5K23AA023869 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The researchers will plan to share individual participant data that underlies the results reported in an article, after deidentification (text, tables, figures, and appendices), Study protocol, and Informed Consent Form.
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication.
IPD Sharing Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
Penn State UniversityNot yet recruiting
-
University of WyomingRecruiting
-
Boston University Charles River CampusActive, not recruiting
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
The Hong Kong Polytechnic UniversityNot yet recruitingHazardous Drinking | Harmful Alcohol Use
-
The University of Hong KongRecruitingmHealth Intervention | AlcoholHong Kong
-
University of Central FloridaEnrolling by invitationAlcohol Use, Underage | Harmful; Use, AlcoholUnited States
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
Clinical Trials on Brief advice
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedMarijuana Abuse | Alcohol Abuse | Cocaine AbuseUnited States
-
Clinica Universidad de Navarra, Universidad de...University of NavarraCompletedSmoking | Smoking CessationSpain
-
University of British ColumbiaNational Institutes of Health (NIH)Completed
-
Boston Children's HospitalPearl NetworkWithdrawnDrug Abuse | Alcohol Abuse | Tobacco AbuseUnited States
-
Washington University School of MedicineNational Institute on Drug Abuse (NIDA)CompletedSmoking Cessation | Tobacco Use Disorder | Tobacco Use CessationUnited States
-
Basque Health ServiceCompletedSmoking Cessation | COPDSpain
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHyperglycemia | Glucose Metabolism Disorders | Metabolic Diseases | Obesity | Diabetes Mellitus | Endocrine System Diseases | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Signs and SymptomsUnited States
-
Pennsylvania Department of HealthChildren's Hospital of Philadelphia; University of Pittsburgh; Lehigh Valley...Unknown